LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

Home・Akciju saraksts・Definitive Healthcare Corp

Definitive Healthcare Corp

Slēgts

SektorsVeselības aprūpe

1.23 -20.65

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

1.23

Max

1.23

Galvenie mērījumi
By Trading Economics
Ienākumi	-8.5M -18M
Pārdošana	-704K 60M
Peļņas marža	-29.631
Darbinieki	782
EBITDA	-8.7M -209K

Rekomendācijas
By TipRanks
Rekomendācijas	Neitrāls
Prognoze 12 mēnešiem	+152.32% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 26. febr.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-132M 165M
Iepriekšējā atvēršanas cena	21.88
Iepriekšējā slēgšanas cena	1.23

Tehniskais rādītājs

By Trading Central

Pārliecība

Bearish Evidence

2.6467 / 2.82 Atbalsts un pretestība

Definitive Healthcare Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 22. febr. 23:55 UTC

Tirgus saruna

Gold and Silver Rise Amid Renewed Trade Tensions -- Market Talk

2026. g. 22. febr. 23:53 UTC

Tirgus saruna

Japan Activity Data Set to Show Strength, Backed by Fiscal Spending -- Market Talk

2026. g. 22. febr. 23:53 UTC

Tirgus saruna

Key China Rates Likely to Be Held Steady for Now -- Market Talk

2026. g. 22. febr. 23:51 UTC

Tirgus saruna

Bank of Korea Set to Hold Fire as Inflation Steadies, Risks Linger -- Market Talk

2026. g. 22. febr. 23:35 UTC

Tirgus saruna

Oil Falls Amid Prospect That U.S. Strike on Iran Might Be Limited -- Market Talk

2026. g. 22. febr. 23:21 UTC

Peļņas

Nickel Industries 2025 Adjusted Ebitda US$283.0 Million

2026. g. 22. febr. 23:20 UTC

Peļņas

Nickel Industries 2025 Operating Profit US$126.4 Million

2026. g. 22. febr. 23:19 UTC

Peļņas

Nickel Industries 2025 Revenue US$1.65 Billion, Down 5.5% On-Year

2026. g. 22. febr. 23:19 UTC

Peļņas

Correct: Nickel Industries 2025 Net Loss US$57.1 Million, Down 66% On-Year

2026. g. 22. febr. 23:18 UTC

Peļņas

Nickel Industries Won't Pay a Final Dividend

2026. g. 22. febr. 23:16 UTC

Peļņas

Nickel Industries 2025 Net Loss A$57.1 Million, Down 66% On-Year

2026. g. 22. febr. 21:35 UTC

Peļņas

Ampol Expects to Start Commissioning of Ultra Low Sulfur Fuels Project in 2Q

2026. g. 22. febr. 21:34 UTC

Peļņas

Ampol Says F&I Australia, International Have Begun 2026 Strongly

2026. g. 22. febr. 21:34 UTC

Peļņas

Ampol Expects Stage 1 of Fuel Security Services Payment Review Finalized in 1Q

2026. g. 22. febr. 21:33 UTC

Peļņas

Ampol Says Lytton Refiner Margin Was US$8.13/bbl in January

2026. g. 22. febr. 21:33 UTC

Peļņas

Ampol Recognizes A$89.9 Million Impairment in Carrying Value of Investment in Seaoil

2026. g. 22. febr. 21:28 UTC

Peļņas

Ampol Final Dividend A$0.60/Share

2026. g. 22. febr. 21:28 UTC

Peļņas

Ampol FY Revenue A$31.37 Billion, Down 10%

2026. g. 22. febr. 21:28 UTC

Peļņas

Ampol FY Replacement-Cost Net Profit A$429.2 Million, Up 83%

2026. g. 22. febr. 21:28 UTC

Peļņas

Ampol FY Historical-Cost Net Profit A$82.4 Million, Down 33%

2026. g. 21. febr. 14:31 UTC

Iegādes, apvienošanās, pārņemšana

Bridgewater Associates' 4Q Buying and Selling -- Barrons.com

2026. g. 21. febr. 05:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2026. g. 20. febr. 23:12 UTC

Iegādes, apvienošanās, pārņemšana

FERC Authorizes TXNM Energy Acquisition by Blackstone Infrastructure

2026. g. 20. febr. 22:12 UTC

Peļņas

Equinox Gold: Announces Filing of 2025 Audited Fincl Statements

2026. g. 20. febr. 21:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 20. febr. 21:50 UTC

Tirgus saruna

Auto & Transport Roundup: Market Talk

2026. g. 20. febr. 21:23 UTC

Peļņas

These Stocks Are Today's Movers: Grail, Corning, Comfort Systems USA, Opendoor, Akamai, Chemours, and More -- Barrons.com

2026. g. 20. febr. 21:20 UTC

Tirgus saruna

Century Aluminum Backs Trump's Tariffs After SCOTUS Ruling -- Market Talk

2026. g. 20. febr. 21:01 UTC

Iegādes, apvienošanās, pārņemšana

Want to Win the Warner Bros. Discovery Takeover Battle? 'Walk Away Now.' -- Barrons.com

2026. g. 20. febr. 20:38 UTC

Tirgus saruna

U.S. Natural Gas Gains Ahead of Chilly Weekend -- Market Talk

Salīdzinājums

Cenas izmaiņa

Definitive Healthcare Corp Prognoze

Cenas mērķis

By TipRanks

152.32% augšup

Prognoze 12 mēnešiem

Vidējais 3.81 USD 152.32%

Augstākais 5 USD

Zemākais 2.75 USD

Pamatojoties uz 5 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Definitive Healthcare Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

5 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 5 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Definitive Healthcare Corp — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

2.6467 / 2.82Atbalsts un pretestība

Recent bearish events outweigh bullish events.

Bearish events outweigh bullish events.

There is one bearish event.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Definitive Healthcare Corp

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.